The ESMO Congress is a highly influential global oncology meeting for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world.
ESMO 2026 will be a platform for breakthroughs in oncology research, clinical practice and patient care. Participants can expect impactful new data, interactive education, excellent networking opportunities and an innovative exhibition area. By attending the ESMO Congress 2026, oncologists will not only gain insights into the latest developments but also play an active role in shaping the future of oncology on a global scale.
A comprehensive educational and scientific programme will foster the exchange and debate of translational cancer science, highlight the first announcements of potentially practice-changing data, and stimulate multidisciplinary discussions aimed at improving treatment options for patients.
Learning objectives:
- To stay informed about current approaches in cancer prevention, screening, and early detection
- To gain insights into the latest advances in basic, translational, and clinical cancer research
- To explore the clinical implications of scientific breakthroughs in cancer biology, diagnostics, and treatment
- To be updated on state-of-the-art therapeutic strategies for patients with cancer
- To examine the emerging role of artificial intelligence in cancer diagnosis, research and therapy
Location: IFEMA Madrid, Madrid, Spain
Key Dates:
Early Registration Deadline: 22 July 2026 at 23:59 CEST
Abstract Submission Deadline: 12 May 2026 at 21:00 CEST
Late-Breaking Abstract Submission Deadline: 8 September 2026 at 21:00 CEST
Conference Dates: 23 October 2026 – 27 October 2026